Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Other Stockholders Equity: ¥1,411 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603882 Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
75 GF Score
Price ¥27.51
GF Value ¥28.07
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Guangzhou Kingmed Diagnostics Group Co Other Stockholders Equity?

Guangzhou Kingmed Diagnostics Group Co SHSE:603882 -0.90% 75 Other Stockholders Equity is ¥1,411 Mil as of Mar. 2026. GuruFocus rates SHSE:603882 with a GF Score™ of 75/100 and a GF Value™ of ¥28.07 (Fairly Valued). The stock has 7 warning signs investors should review.

Guangzhou Kingmed Diagnostics Group Co's Other Stockholders Equity for the quarter that ended in Mar. 2026 was ¥1,411 Mil.

Guangzhou Kingmed Diagnostics Group Co's quarterly Other Stockholders Equity declined from Sep. 2025 (¥1,433 Mil) to Dec. 2025 (¥366 Mil) but then increased from Dec. 2025 (¥366 Mil) to Mar. 2026 (¥1,411 Mil).

Guangzhou Kingmed Diagnostics Group Co's annual Other Stockholders Equity declined from Dec. 2023 (¥402 Mil) to Dec. 2024 (¥380 Mil) and declined from Dec. 2024 (¥380 Mil) to Dec. 2025 (¥366 Mil).

Guangzhou Kingmed Diagnostics Group Co Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Guangzhou Kingmed Diagnostics Group Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Kingmed Diagnostics Group Co Other Stockholders Equity Chart

Guangzhou Kingmed Diagnostics Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 313.42 436.29 402.34 379.78 366.23

Guangzhou Kingmed Diagnostics Group Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,440.18 371.51 1,432.55 366.23 1,411.38
SHSE:603882
75GF Score
Guangzhou Kingmed Diagnostics Group Co Ltd SHSE:603882
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Kingmed Diagnostics Group Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of ¥1,411 Mil mean?
Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) has a Other Stockholders Equity of ¥1,411 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors.
Is Guangzhou Kingmed Diagnostics Group Co's Other Stockholders Equity too high?
Guangzhou Kingmed Diagnostics Group Co's current Other Stockholders Equity is ¥1,411 Mil. Overall, Guangzhou Kingmed Diagnostics Group Co has a GF Score™ of 75/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Kingmed Diagnostics Group Co's Other Stockholders Equity compare to TMO and DHR?
Guangzhou Kingmed Diagnostics Group Co's Other Stockholders Equity of ¥1,411 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Medical Diagnostics & Research company?
A good Other Stockholders Equity depends on the Medical Diagnostics & Research industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guangzhou Kingmed Diagnostics Group Co and its competitors. Guangzhou Kingmed Diagnostics Group Co's current Other Stockholders Equity is ¥1,411 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Kingmed Diagnostics Group Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) is currently considered Fairly Valued. The stock's GF Value™ is ¥28.07, compared to a current price of ¥27.51 — trading 2% below its estimated fair value. The current Other Stockholders Equity is ¥1,411 Mil. Guangzhou Kingmed Diagnostics Group Co's overall GF Score™ is 75/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Guangzhou Kingmed Diagnostics Group Co (SHSE:603882), the current Other Stockholders Equity is ¥1,411 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Kingmed Diagnostics Group Co (SHSE:603882) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Kingmed Diagnostics Group Co stock appears to be undervalued. The current stock price of ¥27.51 is trading 2% below its estimated GF Value™ of ¥28.07. GuruFocus considers Guangzhou Kingmed Diagnostics Group Co to be Fairly Valued.

Key valuation signals for SHSE:603882:

  • Other Stockholders Equity: ¥1,411 Mil
  • GF Value™: ¥28.07 vs. price of ¥27.51 (2% below fair value)
  • GF Score™: 75/100 with 7 warning signs

No single metric tells the full story. See the SHSE:603882 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Kingmed Diagnostics Group Co Business Description

Address International Biological Island spiral three on the 10th, Guangdong Province, Guangzhou, CHN, 510000
Founded in 1994, KingMed is the largest independent clinical laboratory in China. It was listed on the Shanghai Stock Exchange in 2017. As of 2024, KingMed has 50 centralized labs and provides over 4000 test items. Over 90% of its total revenue comes from clinical diagnostics. Furthermore, KingMed has been actively investing in its cold chain logistics. Its service network covers the most intensely populated areas in China.
75GF Score

Get the complete analysis for SHSE:603882

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥27.51
Price
¥28.07
GF Value